PharVision Advisers’s Ready Capital RC Stock Holding History

PharVision Advisers’s Portfolio RC Stock Details RC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-49,449	Closed	-$191K	–	951
2025 Q3	$191K	Buy	+49,449	New	+$209K	0.11%	527

Other funds holding RC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WAM

Waterfall Asset Management New York $163M AUM 0.31% 1-Year Est. Return

MCM

Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PharVision Advisers's RC Position: Q4 2025 in Review

PharVision Advisers sold out of Ready Capital (RC) in Q4 2025, closing a stake of 49,449 shares — an estimated $191K sold.

PharVision Advisers first reported a position in RC in Q3 2025 and held it in 1 quarter. The position peaked at $191K in Q3 2025. 266 funds tracked by Wall St. Rank hold RC as of Q4 2025.

PharVision Advisers reported no remaining Ready Capital position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 49,449 Ready Capital shares in Q4 2025, an estimated $191K.
PharVision Advisers first reported a position in Ready Capital in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Ready Capital position peaked at $191K in Q3 2025.
266 funds tracked by Wall St. Rank held Ready Capital as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.